CVS takes on Mylan’s EpiPen with much cheaper version of an alternative By: MarketWatch January 12, 2017 at 11:13 AM EST Drugstore chain is selling a treatment for life-threatening allergies at roughly a sixth of the price of the EpiPen. Read More >> Related Stocks: CVS Health Corp Mylan